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Abstract
Background: The aim of this study was to determine whether South Asian patients with diabetes have a worse
prognosis following hospitalization for acute myocardial infarction (AMI) compared with their White counterparts.
We measured the risk of developing a composite cardiovascular outcome of recurrent AMI, congestive heart failure
(CHF) requiring hospitalization, or death, in these two groups.
Methods: Using hospital administrative data, we performed a retrospective cohort study of 41,615 patients with an
incident AMI in British Columbia and the Calgary Health Region between April 1, 1995, and March 31, 2002. South
Asian ethnicity was determined using validated surname analysis. Baseline demographic characteristics and co-
morbidities were included in Cox proportional hazard models to compare time to reaching the composite
outcome and its individual components.
Results: Among the AMI cohort, 29.7% of South Asian patients and 17.6% of White patients were identified as
having diabetes (n = 7416). There was no significant difference in risk of developing the composite cardiovascular
outcome (Hazard Ratio = 0.90, 95% CI = 0.80-1.01). However, South Asian patients had significantly lower mortality
at long term follow-up (HR = 0.62, 95% CI = 0.51-0.74) compared to their White counterparts.
Conclusions: Following hospitalization for AMI, South Asian patients with diabetes do not have a significantly
different long term risk of a composite cardiovascular outcome compared to White patients with diabetes. While
previous research has suggested worse cardiovascular outcomes in the South Asian population, we found lower
long-term mortality among South Asians with diabetes following AMI.
Background
Patients with Type 2 diabetes are at increased risk of
cardiovascular morbidity and mortality. Incidence of
initial myocardial infarction has been shown to be much
higher in individuals with diabetes relative to their non-
diabetic counterparts [1]. Mortality from heart disease is
2-4 times greater in adults with diabetes [2]. The inci-
dence of congestive heart failure is 2.5 times the rate of
patients without diabetes. That rate increases to over 10
times in patients under the age of 45 [3].
South Asian patients have a higher prevalence of car-
diovascular disease and cardiovascular mortality
compared to other ethnic groups such as people of Chi-
nese or European ancestry [4]. One of the primary fac-
tors thought to explain this higher prevalence is the
increased prevalence of diabetes among South Asian
patients [5,6]. Overall, diabetes in South Asian patients
is uniformly more prevalent than in White populations
[5]. Moreover, when only examining individuals with
diabetes, some studies still suggest elevated mortality
risk among South Asians [7]. Some authors have found
that diabetes and other conventional risk factors may
not be sufficient to account for the excess cardiovascular
mortality exhibited in South Asians [8]. One possibility
is that the diabetes in South Asian patients is of a more
aggressive variety than in White populations, leading to* Correspondence: apnijjar@gmail.com
1Department of Medicine, University of British Columbia, BC, Canada





© 2010 Nijjar et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
increased cardiovascular complications following acute
myocardial infarction (AMI).
We sought to clarify the risk increase associated with
diabetes among South Asian and White patients follow-
ing hospitalization for an incident AMI. Specifically, we
conducted a retrospective cohort study of persons with
AMI and investigated a composite primary outcome of
mortality, recurrent AMI, and congestive heart failure
(CHF) requiring hospitalization. Outcomes were com-
pared between South Asian and White populations and
with and without the presence of diabetes. Secondary
outcomes were the individual components of the com-
posite outcome: short-term mortality (≤ 30 days follow-
ing index AMI), long-term mortality (> 30 days),
recurrent AMI, and CHF requiring hospitalization.
Methods
Data for this study were obtained from hospital admin-
istrative discharge records of all hospital institutions in
British Columbia (BC) and the Calgary Health Region
Area (April 1, 1994 to March 31, 2003). Hospital admin-
istrative data contain up to 25 diagnoses for each hospi-
tal admission. Index cases of AMI were identified using
validated International Classification of Diseases, 9th
Revision (ICD-9) and 10th Revision (ICD-10) coding
algorithms (410.× and 121.×, respectively). Patients with
a baseline history of diabetes at the time of diagnosis of
AMI were identified using the codes 250.× (ICD-9) and
E10.0-14.9 (ICD-10). Other co-morbid illnesses, socio-
demographic data, and outcomes of AMI recurrence
and hospitalization for CHF were extracted from hospi-
tal administrative data. Mortality data were obtained
from the BC Vital Statistics File and the Alberta Registry
File.
To further characterize the severity of cardiac disease
in a subset of the cases, data on coronary anatomy were
obtained from the BC Cardiac Registry (data provided
by the Provincial Health Services Authority of BC) and
APPROACH cardiac registry files from January 1999 to
December 2002. Cardiac catheterization results were
classified into six categories, namely disease affecting: 1)
single vessel, 2) two vessels, 3) three vessels, 4) left main
coronary artery, 5) three vessels including 95% of the
proximal left anterior descending (LAD) coronary artery,
or 6) normal coronary anatomy. All invasive cardiac
procedures performed in BC and Alberta are recorded
in these registries with accompanying details on type of
procedure and results.
Ethnicity and residence status was determined using
population registries that contain data on all registered
persons within each province. Data from the different
sources were linked via personal health numbers, a 10-
digit unique identifier for health care services that is
assigned to every Canadian resident.
Inclusion and Exclusion Criteria
AMI identification was through validated algorithms
using ICD-9 and ICD-10 codes [9]. Index cases of AMI
were limited to those occurring between April 1, 1995
and March 31, 2002. Patients were excluded if they
were less than 20 years old, had a previous AMI diagno-
sis in the year prior to their admission, and a hospital
stay of less than one day. These criteria, except hospital
stays of less than one day, are in line with the diagnostic
criteria for identifying AMI patients from hospital dis-
charge administrative data set out by the Canadian Car-
diovascular Outcomes Research Team and Canadian
Cardiovascular Society [10]. Excluding patients with
stays of less than one day was instituted in order to
avoid patients who were admitted for one-day cardiac
procedures. Patients were also excluded if they were
non-residents of the province.
Study Variables
Variables of co-morbid illnesses were identified through
ICD-9 and ICD-10 coding algorithms. Diabetes and co-
morbidities in an AMI cohort have been validated for
both ICD-9 and ICD-10 algorithms [11]. During the fis-
cal years of 1995-2000, ICD-9 coding was exclusively
used, thereafter ICD-10 codes were employed. Previous
validation shows that in the example for diabetes, the
ICD-9 coding algorithm had a high level of accuracy
when compared with chart review of 193 patients. Over-
all sensitivity for ICD-9 was 80%, specificity was 98.3%,
PPV was 80%, and NPV was 98.3%. In the same exam-
ple, ICD-10 coding algorithm demonstrated a sensitivity
of 66.7%, specificity of 98.9%, PPV of 83.3%, and an
NPV of 97.2% [11]. The other co-morbid conditions,
based on the Ontario acute myocardial infarction mor-
tality prediction rules, included cardiogenic shock, CHF,
cancer, cerebrovascular disease, pulmonary disease, renal
failure, cardiac dysrhythmias, hypertension, peripheral
artery disease, history of ischemic heart disease, cardiac
arrest, and liver disease [12].
Ethnicity information was not part of the hospital
administrative data set for the AMI cohort. Instead, sur-
name analysis allowed us to separate patients into the
category South Asian (ancestry from India, Pakistan, or
Bangladesh) or Chinese (ancestry from China, Taiwan, or
Hong Kong). Surname analysis was conducted by mer-
ging provincial population registries with the Nam Peh-
chan computer program [13] and Quan’s Chinese name
list [14] to define South Asian and Chinese ethnicity,
respectively. Nam Pehchan’s program has previously
been demonstrated to recognize South Asian surnames
with a sensitivity of 90-94% and positive predictive value
of 63-96% [15]. Furthermore, in the process of validating
the Nam Pehchan program, visual inspection by commit-
tee found only 0.05% of the 356,555 names examined to
have mixed components of South Asian and non-South
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Asian origins [15]. To create the White patient group, we
included all remaining patients who were not categorized
as South Asian or Chinese based on surname analysis.
While the group classified as “White” contained persons
of non-European descent, the overall number was likely
to be quite small. Persons considered part of the visible
minority that are neither Chinese nor South Asian, repre-
sent only 6.67% of BC’s entire population and 5.67% of
Alberta’s population [16]. For the purposes of this study,
the 946 Chinese patients (2.3% of the entire cohort) were
excluded from analysis.
Our measure of socioeconomic status (SES) was resi-
dential postal code level median household income. In
order to control for regional differences in access to care,
we included a variable of distance to the nearest hospital,
calculated between the center of the residential postal
code to the nearest hospital. Revascularization capability
was also determined for each admitting hospital.
In addition to identifying patients with diabetes
through ICD-9 and ICD-10 coding, we ascertained
whether a subset of patients was receiving medical ther-
apy for diabetes. We included prescription drug data for
individuals over the age of 65. Medications in older
adults are funded through PharmaCare, a drug program
that assists eligible residents with prescription drug
costs. The PharmaCare database has extractable pre-
scription information and drug identification numbers
(DIN) were used to detect medications for the treatment
of diabetes (insulins or oral hypoglycemic agents). Only
patients with prescriptions filled prior to the date of
their index AMI were considered in the analysis. This
was done in order to exclude individuals diagnosed with
diabetes after their AMI hospitalization.
Statistical Analysis
The AMI cohort was stratified into categories of
patients with and without diabetes and these groups
were further subdivided into South Asian and White
patients. The four subgroups were then characterized by
clinical, demographic, and socioeconomic variables.
Crude rates of a composite outcome of mortality, recur-
rent AMI, and CHF requiring hospitalization were com-
pared using chi-square analysis. Cox’s proportional hazard
models were then constructed for all outcomes and
adjusted for the following: age (≥ 65 years), sex, income
quintile, distance to the nearest hospital (≥ 50 km), admis-
sion year, admission to a revascularization hospital, and
province. The co-morbid conditions, based on the Ontario
acute myocardial infarction mortality prediction rules,
were also included in the model [12]. We used analysis of
deviance residuals to test for possible violations of the pro-
portional hazards assumption for all Cox models. Analyses
were performed with SAS statistical software version 9.1
(SAS Institute Inc, Cary, North Carolina).
Results
We identified a total of 40,669 persons with AMI during
the study period. Index cases of AMI were followed for
up to eight years (mean of 3.5 years) after their initial
admission. There were 2190 South Asian (5.4%) and
38,479 White (94.6%) patients. Among the entire cohort,
7416 (18.2%) were coded as having diabetes and these
patients were further subdivided by ethnicity (Table 1).
Diabetes was more common among South Asian
patients at a prevalence of 29.7% compared to 17.6% of
White patients. South Asians with diabetes were
younger, lived closer to a hospital, and occupied the
lower quintiles of socio-economic status (Table 1).
While there were significantly more South Asians with
diabetes, they generally tended to have similar rates of
other co-morbidities.
We evaluated coronary anatomy data from the respec-
tive cardiac registry files of BC and Alberta. Cardiac
catheterization was performed on a total of 2235
patients with diabetes and 9452 patients without dia-
betes (i.e., 28% of the total cohort). Among the patients
with diabetes who received cardiac catheterization, there
were only significant differences detected among the
patients with single vessel disease, with 45 South Asian
patients (20%) in this category, compared to 281 (13.5%)
White patients (p-value = 0.004). South Asians with dia-
betes were not more likely to have more severe coronary
disease. Furthermore, there were no significant differ-
ences between the two ethnic groups in terms of left
ventricular function.
Pharmacologic data were available for 4978 patients
with diabetes, aged 65 and over. Of the 363 South Asian
patients with diabetes, 56 (15.4%) were on no diabetes
medications, 240 (66.1%) were on oral glucose-lowering
medication, and 67 (18.5%) taking insulin. Among
White patients with diabetes, 1104 (23.9%) were on no
diabetes medications, 2557 (55.4%) on oral glucose-low-
ering medication, and 954 (20.7%) taking insulin. South
Asian patients were more likely to be taking oral medi-
cations whereas White patients were more likely to be
on no medications (p = 0.0002). There were no differ-
ences in the proportion of South Asian and White
patients using insulin.
Outcomes
In unadjusted analyses, the composite outcome and its
components of mortality and recurrent AMI were signif-
icantly different between South Asians and Whites.
Among those with diabetes, South Asian patients were
20% more likely to experience a recurrent AMI but
White patients were 11% more likely to reach the com-
posite outcome and 42% more likely to die. Occurrence
of CHF did not differ significantly between South Asian
and White patients (Table 2).
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Within both ethnic groups, the presence of diabetes
was associated with a higher risk of developing the com-
posite outcome. Compared to South Asian patients
without diabetes, unadjusted analyses showed those with
diabetes were 28% more likely to reach the composite
outcome and 50% more likely to die. Results among
White patients showed similar trends with those of
South Asian patients (data not shown).
Table 3 shows hazard ratios (HR), adjusted for base-
line characteristics, for South Asian compared to White
patients. Among patients with diabetes, there was no
significant difference in reaching the composite out-
come. The risk of long-term mortality was decreased by
over a third in South Asian patients with diabetes (HR
= 0.62, 95% CI = 0.51-0.74). The other components of
the composite outcome showed no significant differ-
ences between ethnic groups.
When examining adjusted regression models within
each ethnic group, patients with diabetes had a higher
risk of reaching the composite outcome (data not
shown). Both South Asian and White patients with dia-
betes had an HR of 1.25 compared to patients without
diabetes (South Asian 95% CI = 1.09-1.43; White 95%
CI = 1.21-1.30) for risk of developing the composite
outcome. Short-term mortality was not significantly dif-
ferent in South Asian patients with diabetes when com-
pared to their non-diabetic counterparts. However
among White patients with diabetes, the HR was 1.11
(95% CI = 1.02-1.21) for short term mortality. In com-
paring long-term mortality, both South Asians and
Whites with diabetes had a higher risk than patients
without diabetes. South Asian patients had an HR of
1.44 (95% CI = 1.13-1.83) while White patients’ HR was
1.51 (95% CI = 1.43-1.59) for death occurring greater
than 30 days after the index admission.
In our subset of patients 65 and over, for whom we
had pharmacologic data, we found insulin use correlated
with significantly worse outcomes. Ethnic specific
Table 1 Baseline Characteristics of AMI Cohort
Diabetes (n = 7416) Non-Diabetes (n = 33253)
South Asian (%)
n = 651 (29.7)
White (%)
n = 6765 (17.6)
South Asian (%)
n = 1539 (70.3)
White (%)
n = 31714 (82.4)
Women 239 (36.7) 2603 (38.5) 380 (24.7) 10156 (32.0)
Age ≥ 65 years 350 (53.8) 4603 (68.0) 778 (50.6) 19648 (62.0)
Distance > 50 km† 76 (11.7) 1983 (29.3) 208 (13.5) 10372 (32.7)
Income-1st quintile∞ 162 (24.9) 1473 (21.8) 355 (23.1) 6325 (19.9)
Income-2nd quintile 171 (26.3) 1335 (19.7) 405 (26.3) 5976 (18.8)
Income-3rd quintile 115 (17.7) 1272 (18.8) 302 (19.6) 5812 (18.3)
Income-4th quintile 111 (17.1) 1226 (18.1) 227 (14.7) 6012 (19.0)
Income-5th quintile 80 (12.3) 1147 (17.0) 210 (13.6) 6047 (19.1)
Heart Failure 180 (27.6) 1942 (28.7) 261 (17.0) 5115 (16.1)
Hypertension 271 (41.6) 2712 (40.1) 399 (25.9) 7257 (22.9)
Renal Failure 59 (9.1) 442 (6.5) 46 (3.0) 752 (2.4)
Peripheral Vascular Disease 19 (2.9) 453 (6.7) 21 (1.4) 1133 (3.6)
Cardiogenic Shock 16 (2.5) 160 (2.4) 25 (1.6) 486 (1.5)
Pulmonary Disease 3 (0.5) 57 (0.8) 9 (0.6) 143 (0.5)
Cerebrovascular Disease 19 (2.9) 305 (4.5) 25 (1.6) 815 (2.6)
Dysrhythmia 83 (12.7) 1040 (15.4) 197 (12.8) 4863 (15.3)
Cardiac arrest 17 (2.6) 93 (1.4) 41 (2.7) 559 (1.8)
* Percentages are calculated within each ethnicity
† Calculated distance from patient’s home to nearest hospital
∞ Income percentages do not equal 100% due to missing data. Income quintiles are in order of lowest to highest.
Table 2 Unadjusted outcomes according to diabetes status and ethnicity
Diabetes Non-Diabetes
South Asian (%) White (%) p-value South Asian (%) White (%) p-value
Composite 344 (52.8) 3947 (58.3) 0.01 636 (41.3) 14673 (46.3) 0.0001
Mortality 186 (28.6) 2755 (40.7) < 0.0001 294 (19.1) 8678 (27.4) < 0.0001
Recurrent AMI 185 (28.4) 1563 (23.1) 0.002 373 (24.2) 6873 (21.7) 0.02
CHF 115 (17.7) 1116 (16.5) 0.44 121 (7.9) 2759 (8.7) 0.25
*Composite outcome consists of death, recurrent AMI, or congestive heart failure requiring hospitalization
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analyses were not carried out due to small sample sizes
in the South Asian patient group. Overall, patients tak-
ing insulin developed our pre-specified outcomes more
often than patients with diabetes who were not taking
any hypoglycemic treatment. Hazard ratios were as fol-
lows (data not shown): Composite outcome–HR = 1.25
(95% CI = 1.13-1.39); Mortality–HR = 1.28 (95% CI =
1.14-1.44); Recurrent AMI–HR = 1.22 (95% CI = 1.02-
1.45); and CHF–HR = 1.40 (95% CI = 1.16-1.68). There
were no significant differences when comparing oral
hypoglycemic treatment to no treatment.
Discussion
Our results demonstrate that among those with diabetes
and incident AMI, South Asian patients were not at a
higher risk than White patients for a pre-defined com-
posite outcome that included death, recurrent AMI, and
CHF requiring hospitalization. Our study indicates that
diabetes appears to confer similar risk increases follow-
ing hospitalization for AMI in this population, irrespec-
tive of ethnicity.
Aside from the primary composite outcome, South
Asian patients had significantly lower long-term mortal-
ity following AMI than compared to White patients.
The mortality findings differ from previous studies
reporting equivalent survival [17-21] among South
Asians following AMI. None of these studies adjusted or
matched for the presence of diabetes. Wilkinson, et al,
reported poorer survival among South Asians, but after
adjusting for the presence of diabetes, the excessive risk
was removed [22]. Most recently, Fischbacher, et al,
from Scotland showed improved survival after AMI
among South Asians in a cohort of 4.6 million people,
while adjusting for hospital admission for diabetes [23].
Their data suggests that the traditionally high rate of
cardiovascular mortality in South Asians may be due to
a higher incidence of cardiovascular events as opposed
to higher case fatality.
Our study varied in several respects to previous work
showing equivalent outcomes between South Asians and
White populations following AMI. No previous studies
used a composite outcome of fatal and non-fatal events.
Some studies only examined short-term mortality (< 1
month) or in-hospital mortality [17,20,21]. Most studies
were matched case control studies involving patients
admitted to the hospital [17,18,21] and may be prone to
selection bias.
While South Asian patients did no worse than their
White counterparts, as expected, patients with diabetes
overall did worse than patients without diabetes. How-
ever, the suggestion that diabetes portends a worse prog-
nosis in South Asians is not supported by our study.
Although, the previously mentioned studies only
included patients with confirmed AMI and did not focus
on patients with diabetes, other routine mortality data
from the UK found that the presence of diabetes dispro-
portionately increased the risk of ischemic heart disease
mortality in South Asians. Chaturvedi, et al, found that
individuals with diabetes and of European descent had
mortality rates that were 1.5 times that of individuals
without diabetes. In South Asians, that number went up
to 3 times [7]. Very similar results were found in a gen-
eral population-based sample of South Asian migrants in
the UK by Forouhi, et al. Over 3000 patients were fol-
lowed for over 15 years (1988-2006) and comparisons
made for coronary heart disease mortality. Again, they
found that diabetes increased the mortality risk nearly
three-fold compared to South Asian patients without dia-
betes at baseline. In White patients with diabetes, the
excess mortality was 1.5-fold [8]. Our results showed an
increased risk of long-term mortality of about 1.5 times
for both South Asian and White patients, indicating no
significant differential impact of diabetes in South Asians,
following hospitalization for AMI.
The earlier UK mortality study by Chaturvedi, et al,
did have a different methodology in that they examined
routine mortality data from 1985-1986, extracting
records that listed diabetes anywhere on the death certi-
ficate. Their data included out of hospital death, which
can be affected by a number of factors not included in
either study, including symptom recognition, availability
of emergency medical services, and severity of disease.
Furthermore, the study used data that is over twenty
years old and cardiovascular care has changed
Table 3 Time to event for outcome: Adjusted Hazard Ratios compared to Whites*
Diabetes Non-Diabetes
South Asian (CI) p-value South Asian (CI) p-value
Composite 0.90 (0.80-1.01) 0.070 0.89 (0.83-0.97) 0.006
30 day mortality 0.77 (0.59-1.01) 0.060 0.96 (0.79-1.16) 0.656
> 30 day mortality 0.62 (0.51-0.74) < 0.0001 0.65 (0.56-0.76) < 0.0001
Recurrent AMI 1.17 (1.00-1.36) 0.054 1.06 (0.95-1.18) 0.299
CHF 1.11 (0.91-1.35) 0.298 0.92 (0.77-1.11) 0.403
*Adjusted Cox regression model includes the following variables: sex, age, distance to nearest hospital, admission year, admission to a revascularization hospital,
income quintile, province, and the following co-morbid conditions: heart failure, hypertension, renal failure, peripheral artery disease, cardiogenic shock, cancer,
pulmonary disease, cerebrovascular disease, dysrhythmia, cardiac arrest, and liver disease.
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substantially from this time period. The more recent
population-based study by Forouhi, et al, followed
patients prospectively and also measured overall coron-
ary heart disease mortality. While they attempted to
control for several conventional risk factors, the excess
mortality risk persisted in South Asians. It is possible
they may have included patients with a previous history
of AMI and therefore placing them at a greater risk for
future cardiovascular mortality, whereas our study
excluded such individuals.
In our study, almost half of the South Asian patients
were under the age of 65. This was in contrast to White
patients, in whom only 32% of individuals with diabetes
were under the age of 65 at the time their AMI. The
younger age at first AMI for South Asian patients has
been noted previously [24], but not specifically in patients
with diabetes. Since we found that South Asian patients
are having their AMI at an earlier age, they may be more
likely to come under medical supervision and pursue
aggressive risk factor management, therefore decreasing
their risk of death in the long term. This is consistent with
prospective UK data demonstrating that South Asian
patients were more likely to have cardiac procedures and
be taking secondary prevention drugs than compared to
White patients with similar clinical need [25].
While we found that South Asians with diabetes had
lower long-term mortality, they showed a trend for
being more likely to experience a recurrent AMI. Since
mortality was significantly lower among the South Asian
group, we questioned if patients were surviving longer
and therefore had a greater probability of experiencing a
recurrent AMI. To eliminate this survivor bias, we re-
analyzed the data by removing those patients who had
died and found that the trend of an increased rate of
recurrent AMI in South Asians patients with diabetes
disappeared (HR = 1.00, 95% CI = 0.86-1.17). Survivor
bias may also play a role in our demonstrated lower
mortality among South Asians since only patients diag-
nosed and admitted with AMI were included in the
study. Therefore, we could have missed patients who
had more severe disease and died prior to hospital
admission.
We included drug utilization data on a small subset of
patients. Our results revealed South Asians were more
likely to be prescribed diabetes medications than
Whites. Whether this reflected more severe diabetes or
better control of diabetes among South Asians was not
able to be determined. However, it does provide some
hypothesis-generating information on differing patterns
of drug prescribing and utilization between ethnicities
and its impact on diabetes complications.
Limitations
There are several limitations with this type of study. As
this was a retrospective observational study, we were
not able to adjust for all relevant covariates. We were
unable to include data on risk factors such as diabetes
control, duration of diabetes, tobacco use, physical activ-
ity, obesity, and dyslipidemia. However, tobacco use has
been shown to be less common among certain South
Asian communities [26,27] but it may have more than
an additive effect with diabetes in the risk of AMI [28].
Rates of tobacco use, along with other risk factors,
could in part, explain the increased mortality among
Whites. Although we did adjust for age in our multivari-
ate models, there may be some component of relative
youth that we are unable to control for that is contri-
buting to the lower mortality among South Asians. Mis-
classification of ethnicity may have occurred since we
employed surname algorithms to determine South Asian
ethnicity. While the specificities associated with these
algorithms were high, there may still be some erroneous
categorization of ethnicity. Furthermore, the group of
White patients may consist of some non-White indivi-
duals given that all patients without a South Asian or
Chinese surname were included in this category. This
group of patients is likely to be quite small since the
minority population, excluding South Asians and Chi-
nese, is only about 6% of both BC and Alberta’s overall
population. On the whole, ethnicity misclassification is
likely to be non-differential and would tend to underes-
timate any differences between the study groups. Finally,
although our study focused on a large population-based
cohort, the overall number of South Asian patients
remained relatively small.
Conclusions
Although some speculate that South Asian patients pos-
sess a particularly malignant form of diabetes compared
to others, our study shows South Asian patients with dia-
betes do not have a significantly different prognosis for
fatal and non-fatal events following hospitalization for
AMI, compared to White patients with diabetes. In fact,
South Asians patients with diabetes experienced a signifi-
cantly lower mortality rate following hospitalization for
AMI. Further research is necessary to better characterize
the complex factors that are driving these findings.
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